ΠΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Π±Π΅Π»ΠΊΠΎΠ² ΠΎΠ±Π»Π°ΡΡΠΈ pX Π²ΠΈΡΡΡΠ° Π’-ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ Π»Π΅ΠΉΠΊΠΎΠ·Π° ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° I ΡΠΈΠΏΠ° Π² ΠΊΠ»Π΅ΡΠΊΠ°Ρ Escherichia coli ΠΈ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΡΡ Π±Π΅Π»ΠΊΠΎΠ² Π² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅
ΠΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΡ
ΠΠ°ΡΡΠ½Π°Ρ Π½ΠΎΠ²ΠΈΠ·Π½Π° Π΄Π°Π½Π½ΠΎΠΉ ΡΠ°Π±ΠΎΡΡ Π·Π°ΠΊΠ»ΡΡΠ°Π΅ΡΡΡ Π² ΡΠΎΠΌ, ΡΡΠΎ Π² Π½Π°ΡΡΠΎΡΡΠ΅ΠΉ ΡΠ°Π±ΠΎΡΠ΅ Π΄Π»Ρ ΠΊΠ»ΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π³Π΅Π½ΠΎΠ² tax ΠΈ rex HTLV-I Π±ΡΠ»ΠΈ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½Ρ Π½Π΅ΡΠΊΠΎΠ»ΡΠΊΠΎ Π²Π°ΡΠΈΠ°Π½ΡΠΎΠ² ΠΏΠ»Π°Π·ΠΌΠΈΠ΄Π½ΡΡ Π²Π΅ΠΊΡΠΎΡΠΎΠ² Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠΌΠΈ ΡΠΈΠΏΠ°ΠΌΠΈ ΠΏΡΠΎΠΌΠΎΡΠΎΡΠΎΠ², ΠΊΠΎΡΠΎΡΡΠ΅ Π½Π΅ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π»ΠΈΡΡ ΡΠ°Π½Π΅Π΅ Π΄Π»Ρ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ Π±Π΅Π»ΠΊΠΎΠ² Tax ΠΈ Rex HTLV-I. ΠΡΠ»ΠΈ ΠΏΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Ρ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ Π°ΠΌΠΈΠ½ΠΎΡΠ΅ΡΠΌΠΈΠ½Π°Π»ΡΠ½ΠΎΠΉ, ΠΊΠ°ΡΠ±ΡΠΎΠΊΡΠΈΡΠ΅ΡΠΌΠΈΠ½Π°Π»ΡΠ½ΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠ΅ΠΉ Tax, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΏΠΎΡΡΠΈ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΡΡΡΠ΅Π²ΠΈΡ Π.Π., Π‘Π΅Π½ΡΡΠ° Π. Π. /HTLV-I: ΡΡΡΡΠΊΡΡΡΠ½ΡΠ΅ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π³Π΅Π½ΠΎΠΌΠ°, Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅, ΡΠ²ΠΎΠΉΡΡΠ²Π° ΠΈ ΡΠΈΠ»ΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ·./ ΠΠΠ§/Π‘ΠΠΠ ΠΈ ΡΠΎΠ΄ΡΡΠ²Π΅Π½Π½ΡΠ΅ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ 1997,1, № 1, Ρ.52−60.
- ΠΡΡΡΠ΅Π²ΠΈΡ Π.Π., Π‘Π΅Π½ΡΡΠ° Π. Π., ΠΠΈΠ²Π½ΠΈΠΊ Π. Π. ΠΈ Π΄Ρ. / ΠΠ΅ΡΠ²ΡΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠΉ Π² Π‘Π‘Π‘Π ΡΠ»ΡΡΠ°ΠΉ Π’-ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ Π»Π΅ΠΉΠΊΠΎΠ·Π° Π²Π·ΡΠΎΡΠ»ΡΡ (ATL) Ρ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠΌ ΠΈΠΌΠΌΡΠ½Π½ΡΠΌ ΠΎΡΠ²Π΅ΡΠΎΠΌ ΠΊ HTLV-I. / ΠΠΎΠΏΡ. ΠΎΠ½ΠΊΠΎΠ». 1991, 37,5, Ρ.563−567.
- ΠΠ°Π²Π»ΠΈΡ Π.Π. ΠΠΈΡΡΡ Π’-ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ Π»Π΅ΠΉΠΊΠΎΠ·Π° Π² Π ΠΎΡΡΠΈΠΈ: ΡΠ΅ΡΠΎΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅, Π²ΠΈΡΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ. ΠΠ²ΡΠΎΡΠ΅Ρ. Π΄ΠΈΡ. Π΄ΠΎΠΊΡ. ΠΌΠ΅Π΄ΠΈΡ. Π½Π°ΡΠΊ 1999, ΠΠΎΡΠΊΠ²Π°.
- Π‘Π°Π½ΠΊΠΎΠ² Π.Π. ΠΠ»ΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΈ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Π³Π΅Π½ΠΎΠ² ΡΡΡΡΠΊΡΡΡΠ½ΡΡ Π±Π΅Π»ΠΊΠΎΠ² HTLV-I Π² Π±Π°ΠΊΡΠ΅ΡΠΈΡΡ Escherichia coli. ΠΠ²ΡΠΎΡΠ΅Ρ. Π΄ΠΈΡ. ΠΊΠ°Π½Π΄. Π±ΠΈΠΎΠ». Π½Π°ΡΠΊ ~ 1995.
- Π‘Π΅Π½ΡΡΠ° Π.Π., Π―ΠΊΠΎΠ²Π»Π΅Π²Π° Π. Π‘., Π‘ΡΠ΅ΠΏΠΈΠ½Π° Π.Π.ΠΈ Π΄Ρ. /ΠΠ½ΡΠΈΡΠ΅Π»Π° ΠΊ HTLV-I Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ°Ρ Π΄ΠΎΠ½ΠΎΡΠΎΠ² ΠΊΡΠΎΠ²ΠΈ, ΠΏΡΠΎΠΆΠΈΠ²Π°ΡΡΠΈΡ Π² ΡΠ΅ΡΠΏΡΠ±Π»ΠΈΠΊΠ°Ρ Π‘ΡΠ΅Π΄Π½Π΅ΠΉ ΠΠ·ΠΈΠΈ ΠΈ ΠΠ°Π·Π°Ρ ΡΡΠ°Π½Π°./ ΠΠΎΠΏΡ. Π²ΠΈΡΡΡΠΎΠ». ~ 1991, 4, Ρ.328−331.
- Π‘ΡΠ΅ΠΏΠΈΠ½Π° Π.Π., Π‘Π΅Π½ΡΡΠ° Π. Π., ΠΠ°ΠΊΠΈΠ΅Π²Π° Π. Π. ΠΈ Π΄Ρ. / Π‘Π΅ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ Π²ΠΈΡΡΡΠ° Π’-ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ Π»Π΅ΠΉΠΊΠΎΠ·Π° Π² (HTLV-I) Π’ΡΡΠΊΠΌΠ΅Π½ΠΈΡΡΠ°Π½Π΅./ ΠΠΎΠΏΡΠΎΡΡ Π²ΠΈΡΡΡΠΎΠ»ΠΎΠ³ΠΈΠΈ-1996, № 4, Ρ. 174−178.
- Π‘ΡΡΡΠ΅Π² Π.Π. ΠΠΊΡΠΏΡΠ΅ΡΡΠΈΡ ΠΏΡΠΎΠ΄ΡΠΊΡΠΎΠ² Π³Π΅Π½ΠΎΠ² env ΠΈ gag HTLV-I Π² E.coli, ΠΈΡ Π°Π½Π°Π»ΠΈΠ· ΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ Π΄Π»Ρ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΡ ΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠ΅Π»Π΅ΠΉ. ΠΠΈΡ. ΠΊΠ°Π½Π΄. ΠΌΠ΅Π΄. Π½Π°ΡΠΊ- 1995, Ρ. 153.
- Π―ΠΊΠΎΠ²Π»Π΅Π²Π° Π.Π‘., ΠΠ°Π²Π»ΠΈΡ Π. Π., Π’ΡΠΏΠΈΡΠΈΠ½ Π. Π., ΠΡΡΡΠ΅Π²ΠΈΡ Π.Π./ ΠΠ°ΡΠΈΠ°Π½ΡΡ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡ Π²ΠΈΡΡΡΠ° Π’-ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ Π»Π΅ΠΉΠΊΠΎΠ·Π° ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° (HTLV-I) Ρ Π-ΠΊΠ»Π΅ΡΠΊΠ°ΠΌΠΈ Π»ΠΈΠΌΡΠΎΠ±Π»Π°ΡΡΠΎΠΈΠ΄Π½ΡΡ Π»ΠΈΠ½ΠΈΠΉ./ ΠΠΎΠΏΡΠΎΡΡ Π²ΠΈΡΡΡΠΎΠ». 1992, № 5−6, Ρ. 232−235.
- Π―ΠΌΠ°ΡΠΈΡΠ° Π, Π‘Π΅Π½ΡΡΠ° Π. Π., ΠΠ°Π²Π»ΠΈΡ Π. Π. ΠΈ Π΄Ρ./ Π Π°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½ΠΈΠ΅ ΠΈ ΡΠΈΠ»ΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΈΠ·ΠΎΠ»ΡΡΠΎΠ² HTLV-I, ΠΏΠ΅ΡΡΠΈΡΡΠΈΡΡΡΡΠΈΡ Π½Π° ΠΠ°Π»ΡΠ½Π΅ΠΌ ΠΠΎΡΡΠΎΠΊΠ΅ Π ΠΎΡΡΠΈΠΈ./ ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½Π°Ρ Π±ΠΈΠΎΠ»ΠΎΠ³Ρ 1995, 29, 5, Ρ. 1172−1182.
- Adachi Y, Copeland TD, Takahashi Π‘, et alJ Phosphorylation of the rex protein of HTLV-l./JBiol Chem. 1992, 267, p. 21 977−21 981.
- Adoud M., Dombrovsky A., Feldman G. et al. / Regulatory elements and leukemogenicity of Human T-Cell Leukemia Viruses type-1 and type-II./ J. of Vir.Dis., 1994, Vol. l,№ 3,p. 31−49
- Ahmed Y.F., Gilmartin G.M., Hanly S.M. et all The HTLV-I Rex Response Element mediates a novel form of rnRNA polyadenylation./ Cell, 1991, Feb. 22, Vol.64, p.727−737
- Ahmed YF, Hanly SM, Malim MH, et alJ Structure-function analyses of the HTLV-I rex and HIV-I rev RNA response elements: insights into the mechanism of rex and rev action./ Genes Dev 1990,4, p. 1014−1022.
- Akiyama Y, Ito K./ Sec Y protein, a membrane-embedded secretion factor of E. coli, is cleaved by the Omp T protease in vitro./ Biochem. Biophys. Res. Commun. 1990, 167, p. 711−715.
- Albrecht Π., Collins ND., Newbound Gc., et all Quantification of human T-cell lymphotropic virus type I proviral load by quantitative competitive polimerase chain reaction./ J Virol Methods 1998, 75(2), p. 123−140.
- Alexandre C, Charnay P, Verrier Π./ Transactivation of Krox-20 and Krox-24 promoters by the HTLV-I tax protein through common regulatory elements./ Oncogene -1991, 6, p. 51−57.
- Ando Y, Nakano S, Saito K, et «/./Transmission of adult T-cell leukemia retrovirus (HTLV-I) from mother to child: Comparison of bottle- with breast-fed babies./ Jpn J Cancer Res 1987, 78, p. 322−324.
- Anonymous./ Licensure of screening tests for antibody to human T-lymphotropic virus type I./ MMWR 1988, Vol. 37, № 48, p. 736−747.
- Ballaun C., Farrington G.K., Dobrovnik M. et ah /Functional analysis of Human T-Cell Leukemia Virus Type I rex-Response Element: Direct RNA Binding of Rex Protein correlates with in vivo activity./ J. Virology 1991, Aug., p.4408−4413
- Baranger AM, Palmer CR, Hamm MK, et al./ Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax./ Nature 1995, 376, p. 606−608.
- BarShira A, Panet A, Honigman A./ An RNA secondary structure juxtaposes two remote genetic signals for HTLV-I RNA Π'-end processing./ J Virology 1991, 65, p. 51 655 173.
- Bartoe J.T., Albrecht B, Collins N.D. et all Functional role of pX open reading frame II of human T-lymphotropic virus type I in maintenance of viral loads in vivo./ J. Virol., 2000, Feb., 74 (3), p.1094−1100
- Beraud C, Lombard-Platet G, Michal Y, et all Binding of the HTLV-I Tax 1 transactivator to the inducible 21 bp enhancer is mediated by the cellular factor HEB1./ EMBOJ- 1991, 10, p. 3795−3803.
- Black Π.Π‘., Chen I.S.Y., Arrigo S. et al. l Regulation of HTLV-II gene expression by rex involves positive and negative cis-acting elements in the 5' long terminal repeat./ Virology, 1991, 181, p.433−444
- Black A.C., Ruland C.T., Yip M.T. et al. l HTLV-II rex binding and activity require an intact splice donor site and specific RNA secondary structure./ J. Virology, 1991,65,p. 6645−6653
- Bogerd H, Greene WC./ Dominant negative mutants of HTLV-I rex and human immunodeficiency virus type I rev fail to multimerize in vivo./ J Virology 1993, 67, p. 2496−2502.
- Bogerd H.P., Tiley L.S., Cullen B.R./ Specific binding of the Human T-Cell Leukemia Virus Type I rex protein to a short RNA sequence located within the Rex-Response Element./ J. Virology, 1992, Dec., p.7572−7575
- Bohnlein E, Siekevitz M, Ballard DW, et al. f Stimulation of the HIV-1 enhancer by the HTLV-I tax gene product involves the action of inducible cellular proteins./ J Virology- 1988, 63, p. 1578−1586.
- Bohnlein S., Pirker P., Hofer L. et al. / Transdominant repressors for Human T-Cell Leukemia Virus Type I Rex and Human Immunodeficiency Virus Type I Rev function. / J. Virology, 1991, Jan., p.81−88
- Bolton Wv, Wylie BR, Kenrick KG, et alt HTLV-I and blood donors./ The Lancet 1989, 10, p. 1324−1325.
- Born M, Helm K, Wernicke D, et al. l Presens of antibodies to human lymphoma-leukemia virus (HTLV-I) in germans with symptoms of the acquired immunodeficiency syndrome (AIDS)./ J Med Virol 1985, 15, p. 57−63.
- Cann AJ, Chen ISY./ Human T-cell Leukemia virus type-I and II. In: Fields BN, Knipe DM.(eds)./ Virology 1990, 2nd edition. Chapter 52, Raven Press LTD. New York, p. 1501−1527.
- Cann JA, Chen ISY./ Human T-cell Leukemia virus types I and II./ Fields Virology- 1996, ch.59,p. 1849−1880.
- Caputo A, Haseltine WA./ Reexamination of the coding potential of the HTLV-I pX region./ Virology 1992, 188, p. 618−627.
- Chen Y-M, Chen S-H, Fu C-Y, et alJ Antibody reactivities to tumor-suppressor protein p53 and HTLV-I Tof, Rex and Tax in HTLV-I-infected people with differing clinical status./ Int J Cancer 1997, 71, p. 196−202.
- Chen Y-M., Okayama A., Lee T-H., et all Sexual transmission of human T-cell leukemia virus type I associated with the presence of anti-Tax antibody./ PNAS USA -1991, Vol.88, p. 1182−1186.
- Chlichlia K, Moldenhauer G, Daniel PT, et alJ Immediate effects of reversible HTLV-I tax function: T-cell activation and apoptosis./ Oncogene 1995, 10, p. 269−277.
- Clarke M, Gelman E, Reitz Jr./ Homology of human T-cell leukemia virus envelope gene with class I HLA gene./ Nature 1983, v. 305, p 60−62.
- Coates S., Harris A., Keitelman E., et all Serological reactivity of recombinant HTLV-I proteins./ J Cell Biochem. 1989, Suppi. 13B, p.266
- Coates S., Harris A., Parkes D., et alJ Serological evaluation of Escherichia coli -expressed human T cell leukemia virus type I env, gag p24 and tax proteins./ J Clin. Microbiology — 1990, p. 1139−1142.
- Collins N.D., Newbound G.C., Albrecht B. et all Selective ablation of human T-celllymphotropic virus type I pl2I reduces viral infectivity in vivo./Blood, 1998, Jun, 15, 91 (12), p.4701−4707
- Delamarter RB, Carr J, Saxton EH. / HTLV-I viral-associated myelopathy after blood transfusion in a multiple trauma patient./ Clin Orthop 1990, 260, p. 191−194.
- Dokhelar M-C, Pickford H, Sodroski J, et alJ HTLV-I p27rex regulates gag and env protein expression./ J. Acq. Imm. Defic. Sindr., 1989, Vol.2, 5, p. 431−440.
- Ehrlich GD, Glaser JB, Abbot MA, et alJ Detection of anti HTLV-I Tax antibodies in HTLV-I enzyme-linked immunosorbent assay — negative individuals./ Blood -1989, Vol 74, 3, p. 1066−1072.
- Ferrer A, Aparicio C, Nogues N, et al. / Expression of catalytically active radish 3-hydroxy-3-methylglutaryl coenzyme A reductase in Esherichia coli./ FEBS Lett 1990, 18,266(1−2), p. 67−71.
- Foulkes NS, Borrelli E, Sassone-Corsi P./ CREM gene: use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription./ Cell -1991,64, p. 739−749.
- Franchini G./ Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection./ Blood 1995, 86, p. 3619−3639.
- Fujii M, Sassone-Corsi P, Verma IM./ C-fos promoter trans-activation by the taxi protein of human T-cell leukemia virus type I./ PNAS USA 1988, 85, p. 8526−8530.
- Fujii M, Tsuchiya H, Chuhjo T, et al. l Interaction of HTLV-I Taxi with p67srf causes the aberrant induction of cellular immediate early genes through CarG boxes./ Genes Dev. 1992, 6, p. 2066−2076.
- Fujii M, Tsuchiya H, Seiki M./ HTLV-I Tax has distinct overlapping domains for transcriptional activation and for enhancer specificity./ Oncogene 1991, 6, p. 2349−2352.
- Fujisawa J, Seiki M, Kiyokawa T, et al. l Functional activation of long terminal repeat of human T-cell leukemia virus type I by transactivator./ PNAS USA 1985, 82, p. 2277−2281.
- Fujisawa J, Seiki M, Sato M, et all A transcriptional enhancer of HTLV-I is responsible for trans-activation mediated by p40x of HTLV-I./ EMBO J. 1986, 5, p. 713 718.
- Fujisawa J, Toita M, Yoshimura T, et a/./The indirect association of human T-cell leukemia virus Tax protein with DNA results in transcriptional activation./ J Virology -1991, 65, p. 4525−4528.
- Furukawa Y, Fujisawa J, Osame M, et ah / Frequent clonal proliferation of HTLV-I (HTLV-I)-infected T cell in HTLV-I-associated myelopathy (HAM-TSP)./ Blood 1992, 80, p. 1012−1016. 108
- Gessain A, Francis H, Sonan T, et al. / HTLV-I and tropical spastic paraparesis in Africa./Lancet 1986, 2, p.698. 116
- Gessain A, Gallo R, Franchini G./ Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. / J Virology 1992, Vol. 66, p. 2288−2295.
- Gessain A, Malet Ch, Robert-Lamblin J, et al. l Serological evidence of HTLV-I but not HTLV-II infection in ethnic groups of Northern and Eastern Siberia J J Acq Imm Def Synd and Hum Retrovirology 1996, 11,4, p.413−414.
- Gibbs WN, Lofters WS, Campbell M, et al. /Non-Hodgkin lymphoma in Jamaica and its relation to adult T-cell leukemia lymphoma./ Ann Intern Med 1987, 106, p. 361 368.
- Gitlin SD, Dittmer J, Reid RL et al. l The molecular biology of human T-cell leukemia virus./ Cullen B, ed, Frontiers of Molecular Biology, Oxford, Oxford University Press 1993, p. 159−192.
- Gitlin SD, Lindholm PF, Marriott S, et al./ Transdominant human T-cell lymphotropic virus type I Tax mutant that fails to localize to the nucleus./ J Virology -1991, 65, p.2612−2621.
- Gonzalez GA, Yamamoto KK, Fisher WH, et all A cluster of fhosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence./ Nature -1989, 337, p. 749−752.
- Gotoh YL, Sugamura K, Hinuma Y. l Healhty carriers of a human retrovirus, adult T-cell leukemia virus (ATLV): demonstration by clonal culture of ATLV-carrying T-cells from peripheral blood./ PNAS USA 1982, 79, p. 4780−4782.
- Goubau P., Desmyter J, Ghesquiere J, et alJ HTLV-II among pygmies./ Nature ~ 1992, V 359, p.201. 10Π
- Grassmann R, Berchtold S., Aepinus C. et al. /In Vitro Binding of Human T-Cell Leukemia Virus rex Proteins to the rex-Response Element of Viral Transcripts./ J. Virology, July 1991, p.3721−3727
- Green PL, Yip MT, Xie Y, et al./ Phosphorylation regulates RNA binding by the human T-cell leukemia virus rex protein./ J Virology 1992, 66, p. 4325−4330.
- Gurtsevitch V, Senyuta N, Shih J, et al. / HTLV-I family infection in Turkmenistan./ IXth International Conference on AIDS, Berlin 1993, p.268.
- Gurtsevitch V, Senyuta N, Stepina V, et al. / HTLV-I familian infection in different regions of the Former Soviet Union (FSU). / AIDS research and human retroviruses. (Tenth Anniversary volum), 1994, V.10,4, p. 487.
- Gurtsevitch V, Senyuta N, Stepina V, et all HTLV-I among Native People of Far Eastern Regions of Russia./ XthInternational Conference on AIDS. Yokohama 1994, V. l, p. 134.
- Gurtsevitch V, Senyuta N, Pavlish O, et alJ HTLV-I positive case of ATL in Georgia (formely USSR)./ Int. J Cancer — 1992, № 51, p. 835−836. 11Π
- Gurtsevitch V, Senyuta N, Shih J, et alJ HTLV-I infection among Nivkhi people in Sakhalin./Int J Cancer 1995, № 60, p. 432−433.
- Hai T, Liu F, Coukos WJ, et alJ Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-bindingheterodimers./ Genes Dev. 1989, 3, p. 2083−2090.
- Hall WW, Liu CR, Schneewind O, et al. / Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides./ Science 1991, 253, p. 317−320.
- Heger P., Rosorius O., Koch C. et al. / Multimer Formation Is Not Essential for Nuclear Export of Human T-Cell Leukemia Virus Type I Rex trans-Activator Protein./ J. Virology, Nov. 1998, p.8659−8668
- Hidaka M., Inoue J., Yoshida M./ Post-transcriptional regulator (rex) of HTLV-I initiates expression of viral structural proteins but suppresses expression of regulatory proteins./ EMBO, 1988, Vol.7, № 2, p.519−523
- Hino S, Doi H, Yoshikuni H, et al / HTLV-I carrier mothers with high-titer antibody are at high risk as a source of infection./ Jpn J Cancer Res (Gann) — 1987, 78, p. 1156−1158.
- Hinuma Y, Komoda H, Chosa T, et al./ Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nationwide seroepidemiologic study./ Int J Cancer 1982, 29, p.631−635.
- Hinuma Y, Nagata Π, Hanaoka M, et al./ Adult T-cell leukemia antigen in an ATL cell line and detection of antibodies to the antigen in human sera./ PNAS USA 1981, v. 78, p. 6476−6480.
- Hinuma Y. / Seroepidemiology of adult T-cell leukemia virus (HTLV-I/ATLV): origin of virus carriers in Japan./ AIDS Res. 1986, 2, p. 517−522.
- Hirata M., Ikematsu H., Nakashima K., et all Higher expression levels of alternatively spliced pX mRNA in human T lymphotropic virus type I asymptomatic carriers positive for antibodies to p40tax protein./ J Infect Dis — 1995, 172(4), p. 1098−1102.
- Hofer L., Weichselbraun I., Quick S. et alJ Mutational analysis of the Human T-Cell Leukemia Virus Type I trans- acting rex gene product./ J. Virology, 1991, June, p.3379−3383
- Hope T.J., Bond B.L., McDonald et al. / Effector domains of Human Immunodeficiency Virus Type I Rev and Human T-Cell Leukemia Virus Type I Rex are functionally interchangeable and share an essential peptide motif./ J. Virology, 1991, Nov., p. 6001−6007
- Huang K, Huang Q, Wildung MR et alJ Overproduction, in Esherichia coli, of Soluble Taxadiene Synthase, a Key Enzyme in the Taxol Biosynthetic Pathway./ Protein Expr Purif- 1998, 13, p. 90−96.
- Inoue J, Itoh M, Akizawa T, et alJ HTLV-I rex protein accumulates unspliced RNA in the nucleus as well as in cytoplasm./ Oncogene 1991,6, p. 1753−1757.
- Inoue J-I, Seiki M, Taniguchi T, et al. l Induction of interleukin-2 receptor gene expression by p40x encoded by human T-cell leukemia virus type I./ EMBO J -1986, 5, p. 1883−1888.
- Jeang K-T, Chiu R, Santos E, et all Induction of the HTLV-I LTR by Jun Occurs through the Tax-responsive 21-bp elements./ Virology 1991, 181, p. 218−227.
- Jeang K-T, Widen SG, Seemes Oj, et al. l HTLV-I trans-activator protein, Tax, is a trans-repressor of the human (3-polymerase gene./Science 1990, 247, p.1082−1084.
- Kajiyama W, Kashiwagi S, Ikematsu H, et al /Intra-familial transmission of adult T-cell leukemia virus./ J Infect Dis- 1986, 154, p. 851−857.
- Kamihira S., Toriya K., Amagasaki Π’., et all Antibodies against p40tax gene product of Human T-lymphotropic vims type I (HTLV-I) under various conditions of HTLV-I infection./ Jpn. J Cancer Res-1989, 80, p.1066−1071.
- Kanamori H., Suzuki N., Siomi H. et all HTLV-I p27(rex) stabilizes human interleukin-2 receptor alpha chain mRNA./ EMBO J, 1990, 9, p.4161−4166
- Kaplan JE, Osame M, Kubota H, et al / The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I./ J Acquir Immune Defic Syndr 1990, 3, p. 1096−1101.
- Kashiwagi S., Kajiyama W., Hayashi J., et al/ Antibody to p40tax protein of Human T-cell leukemia virus I and infectivity./ J Infect Dis 1989, 161, p.426−429.
- Kellerman Π Π, Ferenchi Π’. / Maltose -binding protein from E.coli./ J Methods in Enzymology 1982, 90, p. 459−463.
- Kelly K, Davis P, Mitsuya H, et all A high proportion of early response genes are constitutively activated in T-cells by HTLV-I./ Oncogene 1992, 7, p. 1463−1470.
- Kinoshita K, Hino S, Amagasaki T, et all Demonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers./ Gann 1984, 75, p. 103−105.
- Kitajima Π’., Itamura S., Hamakado Π’., et al. l Synthesis of proteins in Escherichia coli immunoreactive with sera from individuals infected with human T-cell leukemia virus type 1.1 Mol Cell Probes 1988, 2,39−46.
- Kiyokawa T, Seiki M, Iwashita S, et al. l p27x-III and p21x-III, proteins encoded by the pX sequence of human T-cell leukemia virus type 1.1 PNAS USA, 1985, Vol. 82, p. 8359−8363.
- Kline RL, Brothers T, Halsey N, et al./ Evaluation of enzyme immunoassays for antibody to human T-lymphotropic viruses type I/II./ The Lancet 1991, Vol.337, p.30−33.
- Koralnik I, Fullen J, Franchini./ The pl2!, pl3n and ΡΠΠ11 encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments./ J Virology 1993,67, № 1, p. 2360−2366.
- Koralnik I.J., Gessain A., Klotman M.E. et all Protein isoforms encoded by the pX region of human T-cell leukemia/ lymphotropic virus type I./ PNAS USA, 1992, Sep, 15, 89 (18), p. 8813−8817
- Kroviarski Y, Cochet S, Martineau P, et al. / Evaluation of several affinity chromatographic supports for the purification of maltose-binding protein from Esherichia coliJ J Chromatograph 1993, 633, p. 273−280.
- Kubota S., Nosaka Π’., Cullen B.R. et all Type I Rev and Human T-Cell Leukemia Virus Type I Rex on nucleolar targeting signals./ J. Virology, Vol.65, № 5, p.2452−2456
- Kuroda N, Washitani Y, Shiraki H, et alJ Detection of antibodies to human T-lymphotropic virus type I by using syntetic peptides J Int J Cancer 1990, 45, p. 865−868.
- Lai RB, Giam CZ, Coligan JE et all Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T-cell lymphotropic virus type I associated myelopathy./ J Infect Dis — 1994, 169 (3), p.496−503.
- Landschulz WH, Johnson PF, McKnight SL./ The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins./ Science 1988, 240, p. 17 591 764.
- Leonard WJ, Depper JM, Uchiyama T, et al I A monoclonal antibody that appears to recognise the receptor for human T cell growth factor: partial characterization of the receptor./ Nature 1983, 300, p. 267−269.
- Leung K, Nabel G./ HTLV-I transactivator induces IL-2 receptor expression through an NFkB like factor./ Nature — 1988, 333, p. 776−778.
- Lin K, Kurland I, Xu LZ, et al / Expression of mammalian liver glycolytic/gluconeogenic enzymes in Esherichia coli: recovery of active enzyme is strain and temperature dependent./ Protein Expr Purif- 1990, 1(2), p. 169−176.
- Lindholm PF, Reid RL, Brady JN./ Extracellular Taxi protein stimulates tumor necrosis factor-p and immunoglobulin kappa light chain expression in lymphoid cells./ J Virology- 1992, 66, p. 1294−1302.
- Lolli F, Fredrikson S, Kam-Hansen S, et al. /Increased reactivity to HTLV-I in inflammatory nervous system diseases./ Ann Neurol- 1987,22, p. 67−71.272
- Maniatis T, Fritch E, Sambrook J./ Molecular cloning. Cold Spring Harbor Lab. Press, NY, 1982.
- Markham PD, Salahuddin SZ, Kalyanaraman VS, et al. / Infection and transformation of fresh human umbilical cord blood cells by multiple sources of human T-cell leukemia-lymphoma virus (HTLV-I)./ Int J Cancer 1983, 31, p. 413−420.
- Marriott SJ, Lindholm P, Brown KM, et al. l A 36-kilodalton cellular transcription factor mediates an indirect responsive element in the viral long terminal repeat./ Mol. Cell. Biol- 1990, 10, p. 4192−4201.
- Marriott SJ, Trinh D, Brady JN./ Activation of interleukin-2 receptor alpha expression by extracellular HTLV-I Taxi protein: a potential role in HTLV-I pathogenesis./ Oncogene 1992, 7, p. 1749−1755.
- Marston F.A.O. / The purification of eukaryotic polypeptides synthesized in Esherichia coli. l JBiochem. 1986, 240, p. 1−12.
- Matsumoto M, Nomuta K, Matsumoto T, et al. l Adult T-cell leukemia-lymphoma in Kagoshima District, southwestern Japan: clinical and hematological characteristics./ Jpn J Clin Oncology 1979, 9, p.325−336.
- Matsuoka M, Hagiya M, Hattori T, et al. /Gene rearrangements of T-cell receptor b and Ρ chains in HTLV-I infected primary neoplastic T-cells./ Leukaemia 1988, 2 p. 8490.
- Matthews M-A. H, Markowitz R-B, Dynan WS./ In vitro activation of transcription by the human T-cell leukemia virus type I Tax protein./ Mol. and Cell. Biology 1992, Vol.12, 5, p. 1986−1996.
- Meinl E, Fickenscher H, Thome M, et al. l Anti-apoptotic strategies of lymphotropic viruses J Immunology today 1998, 18, 10, p. 474−479.
- Miyoshi I., Kubonishi I, Yoshimoto S, et al. l Type Π‘ virus particles in a cord T-cell line derived by cocultivating normal cord leukocytes and human leukemic T-cells./ Jpn. J. Cancer Res. 1981, v. 72, p.967−971.
- Monplaisir N, Neisson-Vernant C, Bouillot M, et al. l HTLV-I maternal transmission in Martinique, using serology and polymerase chain reaction./ AIDS Res hum Retroviruses 1993, 9, p. 869−874.
- Mulloy JC, Kislyakova T, Cereseto A, et al. l Human T-cell lymphotropic/leukemia virus type I Tax abrogates p53 induced cell cycle arrest and apoptosis through its CREB/ATF functional domain./ J Virology — 1998, p. 8852−8860.
- Nagashima K, Yoshida M, Seiki. M./ A single species of pX mRNA of HTLV-I encodes trans-activator p40x and two other phosphoproteins./ J Virology 1986, 60, p. 394 399.
- Nagia Π and Thogersen HC. I Generation of (3-globin by sequence-specific proteolysis of hybrid protein produced in Escherichia coli./ Nature- 1987, 309, p. 810−812.
- Nakano S, Ando Y, Ichijo M, et ΠΉ/./Search for possible routes of vertical and horizontal transmission of adult T-cell leukemia virus./ Gann 1984, 75, p. 1044
- Nam SH, Kidokoro M, Shida H, et alJ Processing of gag precursor polyprotein of HTLV-I by virus-encoded protease. / J Virol 1988, 62, p. 3718−3728.
- Noraz N, Benichou S, Madaule P, et alJ Expression of HTLV-I env and tax recombinant peptides in yeast: identification of immunogenic domains./ Virology 1993, 193, p. 80−88
- Nyborg JK, Dynan WS./ Interaction of cellular proteins with the HTLV-I transcriptional control region. Purification of cellular proteins that bind the 21-base pair repeat elements./ J Biol Chem 1990, 265, p. 8230−8236.
- Orita S., Saiga A., Takagi S. et all A novel alternatively spliced viral mRNA transcribed in cells infected with human T-cell leukemia virus type I is mainly responsible for expressing p21X protein./ FEBSLetters, 1991, 295, p.127−134
- Orita S., Tokagi S., Saiga A. et al. l Human T- cell leukaemia virus type I p21X mRNA: constitutive expression in peripheral blood mononuclear cells of patients with adult T- cell leukaemia./ J. General Virology, 1992, 73, p.2283−2289
- Osame M, Kumamoto I, Izumo S, et al. HTLY-I-associated myelopathy (HAM): epidemiology, clinical features and pathomechanism.// Advances in adult T-cell leukemia and HTLV-I research.// Gann. Monogr 1992, 39, p. 57−68.
- Osame M, Matsumoto M, Usuku K, et al. / Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemia-like cells J Ann Neurol- 1987, 21, p. 117−122. 364
- Palmeri D., Malim M. H./ The Human T-Cell Leukemia Vims Type I posttranscriptional trans-activator rex contains a nuclear export signal./ J. Virology, 1996, Sept, p.6442−6445
- Paul NL, Millet I, Ruddle NH./ The lymphotoxin promoter is stimulated by HTLV-I tax activation of NF-ΠΊΠ in human T-cell lines./ Cytokine 1993, 5, p. 372−378.
- Pavlish O, Syrtsev A, Susova O, et al. Env, gag and tax HTLV-I recombinant proteins: significance for diagnostics. 2-nd International Conference «AIDS, Cancer and Human Retroviruses», St-Petersburg, 1993, p.24.
- Popovic M, Lange-Wantzin G, Sarin R, et al. Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma./ PNAS USA 1983, 80, p. 5402−5406.
- Proudfoot N./ Poly (A) Signals./ Cell, 1991, Feb, 22, Vol.64, p.671−674
- Rimsky L, Dodon MD, Dixon EP, et alJ Trans-dominant inactivation of HTLV-I and HIV-I gene expression by mutation of the HTLV-I Rex transactivator./ Nature 1989, 341, p. 453−456.
- Rimsky L, Hauber J, Dukovich M, et alJ Functional replacement of the HIV-1 rev protein by the HTLV-I rex protein./ Nature 1988, 335, p. 738−740.
- Roithmann S, Pique C, Le Cesne A, et alJ The open reading frame I (ORF I)/ORF II part of the human T-cell leukemia virus type I X region is dispensable for p40tax, p27reX, or envelope expression./ J Virology 1994, 68, p. 3448−3451.
- Rudolph DL, Coligan JE, Lai RB, et all Detection of antibodies to trans-activator protein (p40taxl) of human T-cell lymphotropic virus type I by a synthetic peptide- based assay./ Clin Diagn Lab Immunol 1994, 1(2), p. 176−181.
- Saggioro D, Majone F, Forino M, et al./ Tax protein of human T-lymphotropic virus type I triggers DNA damage./ Leuk. Lymph. 1994, 12, p. 281−286.
- Saiga A, Aono Y, Imai J, et al. l Presence of antibodies to p21X and/or p27 rex proteins in sera from human T-cell leukemia virus type I infected individuals./ J Virol Methods — 1996, 57 (2), p. 157−168.
- Sambrook J, Fritsch E, Maniatis Π’./ Molecular cloning. A laboratory manual (second edition)./ Cold Spring Harbor Lab. Press.- 1989.
- Sauter M, Mueller-Lantzsch N./ Characterization of an Epstein-Barr virus nuclear antigen 2 variant (EBNA 2B) by specific sera./ Virus Res. 1987, 8, p. 141−152.
- Sawada T, Tohmatsu J, Obara T, et al. /High risk of mother-to-child transmission of HTLV-I in p40tax antibody-positive mothers./ Jpn J Cancer Res 1989, 80, p. 506−508.
- Seiki M, Hatton S, Hirayama Y, et al. l Human adult T-cell leukemia virus complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA./ PNAS USA 1983, 80, p. 3618−3622.
- Seiki M, Hikikoshi A, Yoshida M, et al. l Expression of the pX gene of HTLV-I general splicing mechanism in the HTLV family./ Science 1985, 228, 4707, p. 1532−1534.
- Seiki M., Inoue J., Hidaka M. et al. l Two cis-acting elements responsible for post-transcriptional trans-regulation of gene expression of human T-cell leukemia virus type I./ PNAS USA 1988, 85, p. 7124−7128.
- Semmes OJ, Jeang K-T./ HTLV-I Tax is a zinc-binding protein: role of zinc in Tax structure and function./ Virology 1992, 188, p. 754−764.
- Semmes OJ, Jeang K-T./ Mutational analysis of human T-cell leukemia virus type I Tax: regions necessary for function determined with 47 mutant protein./ J Virology -1992, Dec., p. 7183−7192.
- Senyta N, Pavlish O, Gurtsevitch V./ Case of adult T-cell leukemia in HTLV-I infected family in Georgia, USSR./ Lancet 1991, 338, p. 1394.
- Senyta N, Syrtsev A, Yamashita M, et al. l Seroepidemiologic and phylogenetic studies of HTLV-I infection in 2 countries of Caspian sea region./Int J Cancer 1998, 77, p. 488−493.
- Shimotohno Π, Takano M, Miwa M, et al. l Structure of the pX protein deduced of a cDNA clone of pX mRNA in cells infected with human T-cell leukemia virus type 1.1 Gann Jap J Cancer Res 1985, 76,1 4, p.241−244.
- Shimoyama M, Minato K, Tobinai K, et al. / Atypical adult T-cell leukemia-lymphoma: diverse clinical manifestations of adult T-cell leukemia-lymphoma./ Jpn J Clin Oncol- 1983, 13, p. 165−187.
- Shimoyama M. /Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. A report from the lymphoma study group (1984−1987)./ Br J Haematol- 1991, 79, p. 437.
- Siomi H, Shida H, Nam SH, et all Sequence requirements for nucleolar localization of human T-cell leukemia virus type I pX protein, which regulates viral RNA processing./ Cell 1988, 55, p. 197−209.
- Sliwkowski M., Teramoto Y., Ferrer R., et all Characterization of human T cell leukemia virus type I p40X protein expressed in E.coli./ Adv. Gene Tech. — 1988, 8, p.228
- Smith JA 1989, Quantitation of proteins, in Current Protocols in Molecular Biology, Ausebel, FM et al.(eds) Greene Publishing and Wiley-Interscience, New York, pp. 10.1.1.-10.1.3.
- Smith M.R. and Greene W. C. / Molecular Biology of the Type I Human T-Cell Leukemia Virus (HTLV-I) and Adult T-Cell Leukemia./ J. Clin. Invest., Vol.87, March 1991, p.761−766
- Sodroski J. I The human T-cell leukemia virus (HTLV-I) transactivator (Tax) protein./ Biochimica et Biophysica Acta 1992, 1114, p.19−29.
- Sodroski JG, Rosen CA, Haseltine WA./ Trans-acting transcriptional activation of the long terminal repeat of human T-lymphotropic viruses in infected cells./ Science -1984, 225, p. 381−385.
- Stong RC, Korsmeyer SJ, Parkin JL, et all Human acute leukemia cell line with the t (4-ll) chromosomal rearrangement exhibits Π lineage and monocytic characteristics./ Blood- 1985, 65, p. 21−31.
- Straus D, Gilbert W./ Chicken triosophosphate isomerase complements in Escherichia coli deficiency./ PNAS USA 1985, 82, p. 2014−2018.
- Sugamura K, Hinuma Y. I human Retroviruses: HTLV-I and HTLV-II./ The retroviridae 1993, Vol. 2, ch. 7, p.399−434.
- Sullivan MT, Williams AE, Fang CT, et al. l Transmission of human T-lymphotropic virus types I and II by blood transfusion: a retrospective study of recipients of blood components./ Arch Intern Med- 1991, 151, p. 2043−2048.
- Susova O, Pavlish O, Scherbak L, Gurtsevitch V. Expression of the HTLV-I Rex and Tax recombinant proteins in E.coli. Xth International Conference on AIDS. Yokohama, 1994, v. l, p,137.
- Susova O, Scherbak L, Pavlish O, Gurtsevich V. Some peculiarities of N- and C-terminal region p40 TAX HTLV-I protein expression in E.coli. 3-rd International Conference «AIDS, Cancer and Related Problems», St. Petersburg, Russia, 1995, p.61.
- Suzuki T, Hirai H, Murakami T, et al./ Tax protein of HTLV-I destabilizes the complexes of NF-ΠΊΠ and 1ΠΊΠ-Π° and induces nuclear translocation of NF-ΠΊΠ for transcriptional activation./ Oncogene 1995, 10, p. 1199−1207.
- Suzuki T, Hirai H, Yoshida M./ Tax protein of HTLV-I interacts with the Rel homology domain of NF-ΠΊΠ p65 and c-Rel proteins bound to the NF-ΠΊΠ binding site and activates transcription./ Oncogene 1994, 9, p. 3099−3105.
- Tajima K, Tominaga S, Kuroishi T, et al./ Geographical features and epidemiological approach to endemic T-cell- leukemia lymphoma in Japan./ Jpn J Clin Oncology 1979, 9, p. 495−504.
- Tan TH, Jia R, Roeder RG./ Utilization of signal transduction pathway by human T-cell leukemia virus type I transcriptional activator./ J Virology 1989, 63, p. 3761−3768.
- Tanaka Y., Masuda M., Yoshida A., et al./ An antigenic structure of the transactivator protein encoded by human T-cell leukemia virus type I (HTLV-I), as defined by a panel of monoclonal antibodies./ AIDS Res Hum Retroviruses — 1992, 8(2), p.227−235.
- Toyoshima H., Itoh M., Inoue J.I., et al./ Secondary structure of the HTLV-I rex-responsive element is essential for rex regulation of RNA processing and transport of unspliced RNAs./ J. Virology, 1990, 64, p.2825−2832
- Trentin B, Rebeyrotte N, Mamoun R./ An enzymatically active form of the HTLV-I reverse transcriptaseis encoded in Pro and Pol ORFs./ HERN: Abs. of third pathogenesis workshop. 28 Feb. 1998. Newsletter. 1999,6.
- Tsujimoto A, Nyunoya H, Morita T, et al./ Isolation of cDNAs for DNA-binding proteins which specifically bind to a Tax-responsive enhancer element in the long terminal repeat of human T-cell leukemia virus type I./ J Virology 1991, 65, p. 1420−1426.
- Tsukahara T, Kannagi M, Ohashi T, et al./ Induction of Bcl-x (L) expression by human T-cell leukemia virus type I Tax through NF-kappa Π in apoptosis-resistant T-cell transfectants with Tax./ J Virology 1999, 73, 10, p. 7981−7987.
- Unge Π’., Solomin L., Melini M. et al./ The rex regulatory protein of human T-cell Lymphotropic virus type I binds specifically to its target site within the viral RNA./ PNAS USA, 1991, 88, p.7145−7149
- Usuku K, Sonoda S, Osame M, et al./ HLA haplotype-linked high immune responsiveness against HTLV-I-associated myelopathy: Comparison with adult T-cell leukemia/lymphoma./ Ann. Neurol. 1988, 23, p. 143−150.
- Virus Taxonomy. Sixth Report of the International Committee on Taxonomy of viruses. Ed. by Murphy F, etal. Springer- Verlag Wien, New York. 1995, p. 193−204.
- Wagner S, Green MR./ HTLV-I tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization./ Science 1993, 262, p. 395−399.
- Weichselbraun I, Berger J, Dobrovnik M, et al. l Dominant-negative mutants are clustered in a domain of the human T-cell leukemia virus type I Rex protein: implications for trans dominance./ J Virology 1992, 66, p. 4540−4545. A
- Weichselbraun I, Farrington GK, Rusche JR, et al. l Definition of the human immunodeficiency virus type I Rev and human T-cell leukemia virus type I Rex protein activation domain by functional exchange./ J Virology 1992, 66, p. 2583−2587. Π
- Weickert MJ, Pagratis M, Curry SR, et al. / Stabilization of apoglobin by low temperature increases yield of soluble recombinant hemoglobin in Esherichia coli. l Appl Environ Microbiol ~ 1997, 63 (11), p. 4313−4320.
- White K.N., Nosaka Π’., Kanamori H. et alJ The nucleolar localisation signal of the HTLV-I protein p27rex is important for stabilisation of IL-2 receptor alpha subunit mRNA by p27rex./ Biochem Biophys Res Commun., 1991, 175, p.98−103
- Wilkinson DL, Harrison RG / Predicting the solubility of recombinant proteins in Esherichia coli. l Bio/technology 1991, 9, p. 443−448.
- Yamada T, Yamaoka S, Goto T, et al./ The human T-cell leukemia virus type I Tax protein induces apoptosis which is blocked by the Bcl-2 protein./ J Virology 1994, 68, p. 3374−3379.
- Yamashita M, Ido E, Miura T, et al. l Molecular epidemiology of HTLV-I in the world./ AIDS hum Retrovirus 1996, V 13, p. 124−131.
- Yip MT, Chen ISY./ Modes of transformation by human T-cell leukemia viruses./ Mol. Biol. Med. 1990, 7, p.33−44.
- Yokota Π’., Cho M-J, Tachibana N., et all The prevalence of antibody to p42 of HTLV-I among ATLL patients in comparison with healthy carriers in Japan./ Int. J Cancer -1989, 43, p.970−974.
- Yoshida M, Fujisawa J./ Positive and negative regulation of HTLV-I gene expression and their roles in leukemogenesis in ATL. Advances in adult T-cell leukemia and HTLV-I research./ Gann Monograph 1992, 39, p. 217−235.
- Yoshida M, Osame M, Kawai H, et al. l Increased replication of HTLV-I in HTLV-I associated myelopathy./ Ann Neurol. — 1989,26, p. 331−335.
- Yoshida M, Seiki M, Hattori S, et Ρ/./Genome structure of human T-cell leukemia virus and its involvement in the development of adult T-cell leukemia./ In «Human-T-cell Leukemia/ Lymphoma Vims», ed. RC Gallo, ME Essex, and L Gross 1984, p.141−148.
- Yoshida M, Suzuki T, Fujisawa J, et al. l HTLV-I oncoprotein Tax and cellular transcription factors./ Current Topics in Microbiology and Immunology 1995, 193, p. 7989.
- Yoshida M., Inoue J., Fujisawa J. et al. /Molecular mechanisms of regulation of HTLV-I gene expression and its association with leukemogenesis./ Genome, Vol.31, № 2, 1989, p.662−667
- Yoshida M./ HTLV-I Tax: regulation of gene expression and disease./ Trends in Microbiology- 1993, Vol. 1, 4, p. 131−135.
- Yoshimura T, Fujisawa J, Yoshida M./ Multiple cDNA clones encoding nuclear proteins that bind to the tax-dependent enhancer of HTLV-I: All contain a leucine zipper structure and basic amino acid domain./ EMBO J. 1989, 9, p.2537−2542.
- Zhao L-J, Giam Π‘-ZJ Human T-cell lymphotropic vims type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair-repeats by protein-protein interaction./ PNAS USA 1992, 89, p. 7070−7074.
- Zhou Z-A, Adachi Y, Maki M, et al. l Expression of post-transcriptional regulatory gene of HTLV-I, rex, in Escherichia coli./ Virus genes 1989, 3,2, p. 153−158.
- Zucker-Franklin D, Gorman JG./ HTLV-I provirus in seronegative healthy blood donors./ The Lancet 1997, Vol 349, 5, p.999.
- Zucker-Franklin D, Pancake BA, Marmor M, et al. l Reexamination of human T-cell lymphotropic virus (HTLV-I/II) prevalence./ PNAS USA 1997, Vol. 94, p.6403−6407.